Disclosure Of Entity's Operating Segments [Text Block]

Ascelia Pharma - Filing #701899

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	—	—	—	- SEK	—	—	—	- SEK	—	—	—	—	—
Tax expense (income)	—	—	—	—	—	—	3 620 SEK	—	—	—	1 050 SEK	—	—	—	—	—
Profit (loss) before tax	—	—	—	—	—	—	129 523 SEK	—	—	—	99 747 SEK	—	—	—	—	—
Profit (loss)	- SEK	—	- SEK	- SEK	125 903 SEK	- SEK	125 903 SEK	125 903 SEK	98 697 SEK	—	98 697 SEK	- SEK	- SEK	- SEK	98 697 SEK	- SEK
Assets	—	333 493 SEK	—	—	—	—	—	—	—	255 374 SEK	—	—	—	—	—	—
Liabilities	—	25 659 SEK	—	—	—	—	—	—	—	19 318 SEK	—	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	—	—	116 559 SEK	—	—	—	85 527 SEK	—	—	—	—	—
Cash flows from (used in) investing activities	—	—	—	—	—	—	38,000 SEK	—	—	—	75 991 SEK	—	—	—	—	—
Cash flows from (used in) financing activities	—	—	—	—	—	—	184 871 SEK	—	—	—	92 725 SEK	—	—	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]